Skip to main content
padlock icon - secure page this page is secure

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

Buy Article:

$59.00 + tax (Refund Policy)

To assess the association between rivaroxaban and warfarin and major bleeding risk in unprovoked venous thromboembolism (VTE) patients.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: anticoagulation; hemorrhage; rivaroxaban; venous thromboembolism; warfarin

Document Type: Research Article

Publication date: February 1, 2019

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more